Search - tctmd.com

Displaying 601 - 620 of 2121

Sort: Relevancy | Date

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

News Conference News ESC 2018

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

August 26, 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

News Conference News ESC 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

August 25, 2018

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

News Daily News

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

Michael O'Riordan

August 21, 2018

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

Discharge Against Medical Advice After PCI Rare but Deadly

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

SCAI Updates Statement on Intracoronary Diagnostic Tools

News Daily News

SCAI Updates Statement on Intracoronary Diagnostic Tools

July 17, 2018

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

July 16, 2018

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

News Daily News

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

July 03, 2018

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

News Daily News

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

June 22, 2018

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

June 08, 2018

Shortfalls in MI Care Hit Lowest Socioeconomic Groups the Hardest

News Daily News

Shortfalls in MI Care Hit Lowest Socioeconomic Groups the Hardest

June 06, 2018

Marijuana and Cocaine Use in Young MI Patients Linked to Mortality Risks

News Daily News

Marijuana and Cocaine Use in Young MI Patients Linked to Mortality Risks

June 04, 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

News Conference News EuroPCR 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

May 31, 2018

“Transient” STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

Trends in P2Y12 Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After PCI, 2008-2016

Presentation

Trends in P2Y12 Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After PCI, 2008-2016

May 21, 2018

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

News Daily News

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

May 09, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.